2014
DOI: 10.1183/09031936.00034614
|View full text |Cite
|
Sign up to set email alerts
|

Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity

Abstract: Childhood asthma is often characterised by elevated exhaled nitric oxide (eNO), decreased lung function, increased airway reactivity and atopy; however, our understanding of when these phenotypic airway characteristics develop remains unclear. This study evaluated whether eNO, lung function, airway reactivity and immune characteristics during infancy are risk factors of asthma at age 5 years. Infants with eczema, enrolled prior to wheezy illness (n=116), had eNO, spirometry, airway reactivity and allergen sens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
29
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(30 citation statements)
references
References 40 publications
1
29
0
Order By: Relevance
“…166 Both single measurements and changes of FeNO (10 ppb, 15 ppb, or an increase of > 60% over baseline) had positive predictive values that ranged from 80 to 90 percent for predicting and diagnosing loss of asthma control after ICS withdrawal. 167 In adult patients with moderate or severe asthma but no clinical symptoms of asthma for at least 6 months in whom ICS dose was reduced by half, FeNO was a statistically independent predictor of success. 168 However, the response of FeNO in adults with moderate persistent asthma undergoing withdrawal of ICS was heterogeneous.…”
Section: Studies Reporting On Feno Use For Ics Reduction or Withdrawalmentioning
confidence: 99%
“…166 Both single measurements and changes of FeNO (10 ppb, 15 ppb, or an increase of > 60% over baseline) had positive predictive values that ranged from 80 to 90 percent for predicting and diagnosing loss of asthma control after ICS withdrawal. 167 In adult patients with moderate or severe asthma but no clinical symptoms of asthma for at least 6 months in whom ICS dose was reduced by half, FeNO was a statistically independent predictor of success. 168 However, the response of FeNO in adults with moderate persistent asthma undergoing withdrawal of ICS was heterogeneous.…”
Section: Studies Reporting On Feno Use For Ics Reduction or Withdrawalmentioning
confidence: 99%
“…One of the strengths of the study by CHANG et al [6] is that it supports the concept that eosinophilic inflammation develops and increases in early childhood, and is a progressive phenomenon. Data from biopsy studies suggest that eosinophilic inflammation, which is a hallmark of asthma in school children, develops between 1 and 3 years of age [15,16].…”
mentioning
confidence: 79%
“…By carrying out serial FeNO measurements between 1 and 5 years of age, or even from birth to school age, better insight into when eosinophilic inflammation starts could be obtained. CHANG et al [6] suggest a gradual increase of FeNO during the study period, although this is somewhat speculative as only two measurements were available. It is well known that FeNO increases with age during childhood [17], and it is remarkable that FeNO does not seem to show this increase in the children who did not have asthma at 5 years of age.…”
mentioning
confidence: 98%
See 2 more Smart Citations